Nuvectis Pharma

Nuvectis Pharma NVCT Stock

$20.24   0.049433%
Add to favorites
Market Cap
$696.03M
LOW - HIGH [24H]
$19.60 - $20.38
VOLUME [24H]
$209.08K
P/E Ratio
0
Earnings per share
-$2.00
ISIN
US67080T1088
Price   Prediction

Nuvectis Pharma Price Chart

Sorry, that's all we've gotfor now...

Nuvectis Pharma (NVCT) stock price today is 20.24 USD on Tech Market Small (+0.05% on the day). Updated .

Nuvectis Pharma NVCT Financial and Trading Overview

Nuvectis Pharma stock price 20.24 USD
Previous Close 20.23 USD
Open 20.17 USD
Bid 14.4 USD x 200
Ask 25.24 USD x 200
Day's Range 19.6 - 20.38 USD
52 Week Range 5.77 - 29.28 USD
Volume 209.08K USD
Avg. Volume 206.58K USD
Market Cap 696.03M USD
Beta (5Y Monthly) -0.211
PE Ratio (TTM) N/A
EPS (TTM) -2 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 35.4 USD

NVCT Valuation Measures

Enterprise Value 555.32M USD
Trailing P/E N/A
Forward P/E -21.083334
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 5.4955196
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Nuvectis Pharma Stock Price History

Beta (5Y Monthly) -0.211
52-Week Change 232.89%
S&P500 52-Week Change 13.32%
52 Week High 29.28 USD
52 Week Low 5.77 USD
50-Day Moving Average 20.61 USD
200-Day Moving Average 15.18 USD

NVCT Share Statistics

Avg. Volume (3 month) 206.58K USD
Avg. Daily Volume (10-Days) 248.35K USD
Shares Outstanding 34.39M
Float 23.01M
Short Ratio 14.54
% Held by Insiders 32.98%
% Held by Institutions 33.85%
Shares Short 2.54M
Short % of Float 10.85%
Short % of Shares Outstanding 7.39%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -36.92%
Return on Equity (ttm) -66.97%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -50454000 USD
Diluted EPS (ttm) -2
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 140.71M USD
Total Cash Per Share (mrq) 4.09 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 9.923
Book Value Per Share (mrq) 3.683

Cash Flow Statement

Operating Cash Flow (ttm) -40294000 USD
Levered Free Cash Flow (ttm) -22523876 USD

Profile of Nuvectis Pharma

Country United States
State NJ
City Fort Lee
Address 1 Bridge Plaza
ZIP 07024
Phone 201 614 3150
Website https://www.nuvectis.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 19

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Q&A For Nuvectis Pharma Stock

What is a current NVCT stock price?

Nuvectis Pharma NVCT stock price today per share is 20.24 USD.

How to purchase Nuvectis Pharma stock?

You can buy NVCT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Nuvectis Pharma?

The stock symbol or ticker of Nuvectis Pharma is NVCT.

Which industry does the Nuvectis Pharma company belong to?

The Nuvectis Pharma industry is Biotechnology.

How many shares does Nuvectis Pharma have in circulation?

The max supply of Nuvectis Pharma shares is 34.39M.

What is Nuvectis Pharma Price to Earnings Ratio (PE Ratio)?

Nuvectis Pharma PE Ratio is now.

What was Nuvectis Pharma earnings per share over the trailing 12 months (TTM)?

Nuvectis Pharma EPS is -2 USD over the trailing 12 months.

Which sector does the Nuvectis Pharma company belong to?

The Nuvectis Pharma sector is Healthcare.

Nuvectis Pharma NVCT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 25136.27 USD —
-0.91
7.74B USD — 24872.41 USD — 25423.09 USD — — 7.74B USD —
us US Tech Health Care IXHC US 1368.29 USD —
-0.34
— — 1358.68 USD — 1373.65 USD — — — —
$2.19T
Total marketcap
$71.03B
Total volume
BTC 59.38%   •   ETH 10.13%
Dominance
Select currency